Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval.

Emily King of Mobile, Alabama, was diagnosed with colon cancer five years ago at the age of 27. She had experienced some diarrhea, abdominal pain and anemia, but having cancer had never entered ...

When we think of cancer, we often focus on the big symptoms, but colorectal cancer comes with side effects that don’t always ...

Alarmed by the color and frequency of the blood in her stool, Mahon was referred to a GI doctor who initially thought she had an autoimmune disease. “Once I got the colonoscopy, she told me that she ...

The Colorectal Cancer (CRC) therapeutics market is seeing a rapid increase in growth with the rising prevalence, advancement in diagnostics and treatment, and growing awareness. Key drivers ...

All but one of the patients saw their tumors shrink or stop growing after receiving ... recruited patients with eight types of cancer: liver, esophagus, rectum, ovaries, lungs, breast, skin ...

"What is a tumor?" This is the fundamental question to answer if we want to treat cancer effectively. Our vision of cancer ...

Outside-in Signaling ... have tried to stop cancer by disabling the mutated proteins that are found in tumors. But many cancers manage to overcome this and continue growing. Now, scientists ...

The waste then moves through the rectum ... cancer has spread and the size of any tumors. Usually, cells follow an orderly process of growth, division, and death. Cancer can develop when cells ...

Dr Dionisia Quiroga, a breast medical oncologist at The Ohio State University Comprehensive Cancer Center, told Stat News the shift of breast cancer from older to younger women could be due to rising ...